Global Neonatal Hypoxic Ischemic Encephalopathy Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 1,040.13 Million |
 Market Size (Forecast Year) |
USD 1,911.00 Million |
 CAGR |
% |
| Major Markets Players |
>全球新生儿缺氧缺血性脑病市场，按症状（呼吸问题、喂养问题、反射缺失、癫痫、阿普伽评分低、肌张力低或高、意识水平改变）、治疗（治疗性低温、药物、其他）、给药方式（注射、口服、其他）、分销渠道（医院药房、零售药房、网上药房）、最终用户（医院、家庭护理、专科诊所、其他）划分 - 行业趋势和预测到 2030 年。
新生儿缺氧缺血性脑病市场分析及规模
缺氧缺血性脑病 (HIE) 又称围产期窒息、新生儿脑病和出生窒息，是指因血流受限和缺氧而导致的一种新生儿脑损伤。它被定义为一种脑损伤，基本上是一个广义术语，用于描述婴儿在出生时或出生前后所遭受的任何伤害。全球新生儿缺氧缺血性脑病患者数量的增加是推动全球新生儿缺氧缺血性脑病市场增长的主要因素之一。
Data Bridge Market Research 分析称，全球新生儿缺氧缺血性脑病市场在 2022 年为 10.4013 亿美元，预计到 2030 年将达到 19.11 亿美元，预计在 2023-2030 年预测期内的复合年增长率为 7.9%。由于新生儿呼吸问题病例不断增加，“呼吸问题”在全球新生儿缺氧缺血性脑病市场的症状部分中占主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
新生儿缺氧缺血性脑病市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
症状（呼吸问题、喂养问题、反射缺失、癫痫、阿普伽评分低、肌张力低或高、意识水平改变）、治疗（治疗性低温、药物、其他）、给药方式（注射、口服、其他）、分销渠道（医院药房、零售药房、网上药房）、最终用户（医院、家庭护理、专科诊所、其他） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Eisai Co. Ltd. (Japan), Pfizer, Inc. (U.S.), Sanofi (France), Teva Pharmaceuticals Industries Ltd. (Israel), Novartis AG (Switzerland), Allergan (Ireland), Merz Pharma (Germany), Johnson & Johnson Services, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bristol-Myers Squibb Company (U.S.), AbbVie Inc. (U.S.), Eli Lilly and Company (U.S.), Takeda Pharmaceutical Company Limited (Japan), Bayer AG (Germany), Biogen (U.S.), AstraZeneca (U.K.), VTV Therapeutics (U.S.), H. Lundbeck A/S (Denmark), TauRx Pharmaceuticals Ltd (U.K.), DAIICHI SANKYO COMPANY, LIMITED (Japan) |
|
Market Opportunities |
|
Market Definition
The global neonatal hypoxic ischemic encephalopathy (NHIE) market refers to the sector focused on the diagnosis, treatment, and management of infants who have experienced oxygen deprivation and subsequent brain injury during or shortly after birth. It encompasses pharmaceutical companies, medical device manufacturers, healthcare providers, research institutions, and regulatory bodies involved in addressing NHIE. The market is driven by the demand for effective interventions to mitigate long-term neurological impairments in affected infants. Factors influencing the NHIE market include research advancements, regulatory policies, healthcare infrastructure, and public awareness of neonatal health issues.
Global Neonatal Hypoxic-Ischemic Encephalopathy Market Dynamics
Drivers
- Rising Awareness and Diagnostic Advances
Increasing awareness among healthcare professionals and the general public about NHIE leadsto improved recognition and diagnosis of the condition. Advances in diagnostic techniques, such as advanced imaging technologies and biomarker identification, contribute to early detection and intervention, driving market growth.
- Research and Development Efforts
Ongoing research and development activities focused on NHIE contribute to the discovery of new therapeutic interventions and treatment modalities. Pharmaceutical companies and research institutions invest in developing neuroprotective agents, novel drug formulations, and innovative therapies, stimulating market growth.
Opportunities
- Advancements in Treatment Options
As research and development efforts continue, there is a possibility of discovering new and improved treatment options for NHIE. This could include novel pharmaceutical interventions, neuroprotective therapies, or innovative approaches such as stem cell therapy or gene therapy. These advancements could lead to more effective and targeted treatments for NHIE, potentially improving patient outcomes.
- Development of Supportive Technologies
The global NHIE market growth may drive the development of new technologies and medical devices specifically designed for the diagnosis, monitoring, and treatment of neonates with hypoxic ischemic encephalopathy. These technologies could include advanced imaging techniques, wearable devices for continuous monitoring, or specialized equipment for neonatal intensive care units (NICUs). Such innovations can enhance the quality of care provided to affected infants and improve overall outcomes.
Restraints/Challenges
- Hindrance in The Expansion of Neonatal Hypoxic-Ischemic Encephalopathy Market
There are various obstacles that may hinder the expansion of the neonatal hypoxic-ischemic encephalopathy market. These challenges include limited treatment options, lack of awareness, and costly treatments. These factors can impede market growth and pose barriers for market players in the forecast period of 2023-2030
This global neonatal hypoxic-ischemic encephalopathy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global neonatal hypoxic-ischemic encephalopathy market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Neonatal Hypoxic-Ischemic Encephalopathy Market Scope
The global neonatal hypoxic-ischemic encephalopathy market is segmented on the basis of symptoms, treatment, mode of administration, distribution channel, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Symptoms
- Breathing Problems
- Feeding Problems
- Missing Reflexes
- Seizures
- Low Apgar Scores
- Low or High Muscle Tone
- Altered Level of Consciousness
Treatment
- Therapeutic hypothermia
- Drugs
- Other
Mode of Administration
- Injectable
- Oral
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
End-User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Global Neonatal Hypoxic-Ischemic Encephalopathy Market Regional Analysis/Insights
The global neonatal hypoxic-ischemic encephalopathy market is analysed and market size insights and trends are provided by country, symptoms, treatment, mode of administration, distribution channel, and end-user as referenced above.
The countries covered in the global neonatal hypoxic-ischemic encephalopathy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global neonatal hypoxic-ischemic encephalopathy market due to the well-established healthcare infrastructure and increases in drug approvals within the region.
Asia-Pacific is expected to witness high growth during the forecast period 2023-2030 because of the developing health care infrastructure and large patient population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global neonatal hypoxic-ischemic encephalopathy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global neonatal hypoxic-ischemic encephalopathy Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global neonatal hypoxic-ischemic encephalopathy market. The data is available for historic period 2023-2030.
Competitive Landscape and Global Neonatal Hypoxic-Ischemic Encephalopathy Market Share Analysis
全球 新生儿缺氧缺血性脑病市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球 新生儿缺氧缺血性脑病市场的关注有关。
全球新生儿缺氧缺血性脑病市场的一些主要参与者包括：
- 卫材株式会社 (日本)
- 辉瑞公司（美国）
- 赛诺菲（法国）
- Teva Pharmaceuticals Industries Ltd.（以色列）
- 诺华公司（瑞士）
- 艾尔建（爱尔兰）
- Merz Pharma（德国）
- 强生服务公司（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- 百时美施贵宝公司 (美国)
- AbbVie Inc.（美国）
- 礼来公司 (美国)
- 武田药品工业株式会社 (日本)
- 拜耳公司（德国）
- Biogen（美国）
- 阿斯利康（英国）
- VTV Therapeutics（美国）
- H. Lundbeck A/S（丹麦）
- TauRx Pharmaceuticals Ltd（英国）
- 第一三共株式会社（日本）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
